Clinical Trials Disrupted During War in Ukraine

Ukraine is recognized as an attractive location for conducting clinical trials. In April there were listed nearly 400 studies in Ukraine by ClinicalTrials.gov. However, due to the continuing war in Ukraine and the sanctions against Russia drug manufacturers had to stop recruiting patients to existing trials and put the launch of new trials on hold.

Vlad Bogin, MD the founder, and CEO of Cromos Pharma, cited several factors that have made Ukraine conducive for clinical trials and the difficulties in the relocation of patients in the current dangerous situation.

Read the article in full here

If you would like to find out more about how Cromos Pharma can support your next projects email bd@cromospharma.com

CONTACT

BD@CROMOSPHARMA.COM

To arrange an introductory meeting and find out how our experience can benefit your next clinical project.